Plasma Biomarker Discovery Service
Make the most of your precious samples: maximized information from minimized sample amount.
Olink Bioscience offers the opportunity to have your precious biobanked plasma samples analyzed for up to 74 potential cancer biomarkers in no more than 2 µL of sample. The 74 protein assays are available in 4 panels, where each assay has been accurately validated for sensitivity, recovery, dynamic range, specificity and precision. Biomarker studies that previously have been limited by poor assay sensitivity, low throughput systems and insufficient sample amount are now feasible in a simple and efficient way through Olink’s Plasma Biomarker Discovery service.
Olink’s multiplexed PLA® immunoassay platform offers great benefits:
- Consumes minimal sample volume – make better use of your precious sample collections
- Highly sensitive – unravel low-abundant proteins not detected before
- Multiplexed – save time and sample by simultaneously analyzing multiple proteins
- Delivers quantified data – discover and obtain accurate information about novel expression patterns
Click here to download the Plasma Biomarker Service Note
Setting up a Plasma Biomarker Discovery contract service with us is a
very simple and fast procedure; you send in your samples (minimum amount, 48) to us, we do
the analysis and send the results back to you. You will without doubt
extract plenty of new high quality data on protein expression patterns
from your samples – publish your novel findings and contribute to the
understanding of human cancer and better diagnosis.
For further information and pricing on our Plasma Biomarker Discovery service, please contact us at info@olink.com or +46 18 4443970.
This test is performed pursuant to licensing arrangements with F. Hoffman-La Roche Ltd and Applied Biosystems, LLC.